Abstract
The incidence of malignant lymphomas in Japan is relatively low compared to that in western European countries and the United States. However, in limited areas in Japan a specific type of lymphoid malignancy called adult T-cell leukemia/lymphoma (ATL), which is caused by human T-cell leukemia virus type I (HTLV-I), is highly prevalent, and there are also many healthy carriers of HTLV-I in the same areas. A cross-sectional seroepidemiological study of HTLV-I showed that the age-specific proportion of healthy HTLV-I carriers in these ATL-endemic areas increased with age, especially over 40, and was higher in females than in males. Three main routes of HTLV-I transmission are recognized: 1) vertical transmission from mother to child mainly through breast milk; 2) horizontal transmission from man to woman through semen, and; 3) parenteral transmission from carrier donor to non-carrier recipient. The annual incidence rate of ATL among HTLV-I carriers is estimated at 2.0 in males and 0.5 in females, and the cumulative risk for ATL in HTLV-I carriers during a 70-year life span is 1%–5%. Possible risk factors for ATL in addition to HTLV-I infection were considered, i.e. genetic factors, environmental factors, nutritional condition, thymus involution etc., but none of these were found to be clearly associated with ATL. To determine whether there exist particularly susceptible hosts for ATL in the ATL endemic areas, HLA types were examined, but no conclusive results on the positive relationships between HLA types and ATL manifestation or HTLV-I infection were obtained. From follow-up studies on the age-specific distribution of HTLV-I carriers in Japan, it is now speculated that the HTLV-I infection rate might have decreased naturally in the more recent generational cohort groups, even in the ATL-endemic areas. However, ATL in Japan is an important subject for study in the field of cancer epidemiology, and several trial intervention programs for the prevention of ATL, such as controls of vertical transmission from mother to child through breast milk, are now ongoing in the ATL-endemic areas of Japan.
Similar content being viewed by others
References
IARC: Cancer incidence in five continents. Vol. 4, 1982
Tajima K, Tominaga S, Suchi T: Epidemiological features of B-cell lymphoma in Japan. Jpn J Clin Oncol 13: 623–32, 1983
Tajima K, Tominaga S, Kuroishi T, Shimizu H, Suchi T: Geographical features and epidemiological approach to endemic T-cell leukemia/lymphoma in Japan. Jpn J Clin Oncol 9 (Suppl. 1): 495–504, 1979
Tajima K, Tominaga S: Epidemiology of adult T-cell leukemia/lymphoma in Japan. In: PK Vogt (ed), Current topics in Microbiology and Immunology: Human T-cell Leukemia Virus. Springer-Verlag, 1985, pp 53–66
The T- and B-Cell Malignancy Study Group: Statistical analysis of immunologic, clinical and histopathologic data on lymphoid malignancies in Japan. Jpn J Clin Oncol 11: 15–38, 1981
Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H: Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50: 481–92, 1977
The T- and B-cell Malignancy Study Group: Statistical analyses of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special references to adult T-cell leukemia/lymphoma: A report of the second nationwide study of Japan. Jpn J Clin Oncol 15: 517–35, 1985
Blattner WA, Kalyanaraman VS, Robert-Guroff M, Lister TA, Galton DAG, Sarin PS, Crawford MH, Catovsky D, Greaves M, Gallo RC. The human type-C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer 30: 257–64, 1982
Catovsky D, Greaves MF, Rose M, Galton DAG, Goolden AWG, McClusky DR, White JM, Lampert I, Bourikas G, Ireland R, Brownell AI, Bridges JM, Blattner WA, Gallo RC: Adult T-cell lymphoma-leukemia in blacks from the West Indies. Lancet I: 639–43, 1982
Merino F, Robert-Guroff M, Clark J, Biondo-Brancho M, Blattner W, Gallo R: Natural antibody to human T-cell leukemia/lymphoma virus in healthy Venezuelan population. Int J Cancer 34: 501–6, 1984
Miller GJ, Pegram SM, Kirkwood BR, Beckles GLA, Byam NTA, Clayden SA, Kinlen LJ, Chan LC, Carson DC, Greaves MF: Ethnic composition, age and sex, together with location and standard of housing as determinants of HTLV-I infection in an urban Trinidadian community. Int J Cancer 38: 801–8, 1986
Fleming AF, Maharajan R, Abraham M, Kulkarni AG, Bhusnurmath SR, Okpara RA, Williams E, Akinsete I, Schneider J, Bayer H, Hunsmann G: Antibodies to HTLV-I in Nigerian blood-donors, their relatives and patients with leukaemias, lymphomas and other diseases. Int J Cancer 38: 809–813, 1986
Biggar RJ, Saxinger C, Gardiner C, Collins WE, Levine PH, Clark JW, Nkrumah FK, Blattner WA: Type-I HTLV antibody in urban and rural Ghana, West Africa. Int J Cancer 34: 215–9, 1984
Williams CKO, Saxinger C, Alabi GO, Junaid TA, Blayney DW, Greaves MF, Gallo RC, Blattner WA: HTLV-associated lymphoproliferative disease: A report of 2 cases in Nigeria. Brit Med J 288: 1495–6, 1984
Temple JJ, Brammer MG, Andes A, Covington S, Rangan S: Adult T-cell leukemia-lymphoma: Unusual features of two patients from a low-incidence area. Cancer 58: 694–8, 1986
Brindle RJ, Eglin RP, Parsons AJ, Hill AVS, Selkon JB: HTLV-I, HIV, hepatitis B and hepatitis delta in the Pacific and south-east Asia: A serological survey. Epidem Inf 100: 153–6, 1988
Manzari V, Gradilone A, Barillari G, Zani M, Collati E, Pandolfi F, de Rossi G, Liso V, Babbo P, Robert-Guroff M, Frati L: HTLV-I endemic in southern Italy: detection of the first infectious cluster in a white population. Int J Cancer 36: 557–9, 1985
Kinoshita K, Kamihira S, Yamada Y, Amagasaki T, Ikeda S, Momita S, Ichimaru M: Adult T-cell leukemia-lymphoma in Nagasaki district. GANN Monogr Cancer Res 28: 167–84, 1982
Hanaoka M, Sasaki M, Matsumoto H, Tankawa H, Yamabe H, Tomimoto K, Tasaka C, Fujiwara H, Uchiyama T, Takatsuki K: Adult T-cell leukemia, histological classification and characteristics. Acta Path Jap 29: 723–38, 1979
Fujishita M: Studies on adult T-cell leukemia II. Anti-ATLA antibody in the families of ATL patients. Jap J Clin Hematol 24: 533–9, 1983
Shimoyama M, Minato K, Tobinai K, Horikoshi N, Ibuka T, Deura K, Nagatani T, Ozaki Y, Inada N, Komoda H, Hinuma Y: Anti-ATLA (Antibody to the adult T-cell leukemia cell associated antigen)-positive hematologic malignancies in the Kanto district. Jpn J Clin Oncol 12: 109–6, 1982
Shibata A, Aoyagi Y, Aoki A: Adult T-cell leukemia observed at Niigata University Hospital. Jpn J Clin Oncol 13: 657–66, 1983
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci 77: 7415–9, 1980
Kalyanaraman VS, Sarngadharan MG, Nakao Y, Ito Y, Aoki T, Gallo RC: Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci 79: 1653–7, 1982
Miyoshi I, Kubonishi I, Sumida M, Yoshimoto S, Hiraki S, Tsubota T, Kobashi H, Lai M, Tanaka T, Kimura I, Miyamoto K, Sato J: Characteristics of a leukemic T-cell line derived from adult T-cell leukemia. Jpn J Clin Oncol 9: 485–94, 1979
Himuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, Shirakawa S, Miyoshi I: Adult T-cell leukemia: Antigen in a ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci 78: 6476–80, 1981
Nakai M, Goto T, Miyoshi H, Sano K, Chosa T, Himuma Y: Reactivity of sera from patients with adult T-cell leukemia (ATL) with type-C virus particles associated with ATL cell lines: Immunoelectron microscopic study. Gann 73: 511–3, 1983
Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus (ATLV) from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci 79: 2031–5, 1982
Popovic M, Reitz MS, Sarngadharan MG, Robert-Guroff M, Kalyanaraman VS, Nakao Y, Miyoshi I, Minowada J, Yoshida M, Ito Y, Gallo RC: The virus of Japanese adult T-cell leukemia is a member of the human T-cell leukemia group. Nature 300: 63–6, 1982
Watanabe T, Seiki M, Yoshida M: ATLV (Japanese isolated) and HTVL (US isolated) are the same strain of retrovirus. Virology 133: 238–41, 1984
Hinuma Y, Goto Y, Sugamura K, Nagata K, Goto T, Nakai N, Kamada N, Matsumoto T, Kinoshita K: A retrovirus associated with human adult T-cell leukemia: In viro activation. Gann 73: 341–4, 1982
Tajima K, Tominaga S, Suchi T, Kawagoe T, Komoda H, Hinuma Y, Oda T, Fujita K: Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen (ATLA): Possible horizontal transmission of adult T-cell leukemia virus. Gann 73: 893–901, 1982
Miyoshi I, Taguchi H, Fujishita M, Niiya K, Kitagawa T, Ohtsuki Y, Akagi T: Asymptomatic type-C virus carriers in the family of an adult T-cell leukemia patient. Gann 73: 339–40, 1982
Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, Kikuchi M, Ichimura M, Yunoki K, Sato I, Matsuo R, Takiuchi Y, Uchino H, Hanaoka M: Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan. A nation-wide seroepidemiologic study. Int J Cancer 29: 631–5, 1982
Maeda Y, Fukuhara M, Takehara Y, Yoshimura K, Miyamoto K, Matsuura T, Morishima Y, Tajima K, Okochi K, Hinuma Y: Prevalence of possible adult T-cell leukemia virus carriers among volunteer blood donors in Japan: A nation-wide study. Int J Cancer 33: 717–20, 1984.
Tajima K, Hinuma Y: Epidemiological features of adult T-cell leukemia virus. In: G Mathe, P Reizenstein (eds), Pathophysiological Respects of Cancer Epidemiology: Immunological, Virological, Endocrinological and Genetical Factors. Pergamon Press, Oxford, 1984, pp 75–87.
Kohakura M, Nakada K, Yonahara M, Komoda H, Imai J, Hinuma Y: Seroepidemiology of the human retrovirus (HTLV/ATLV) in Okinawa where adult T-cell leukemia is highly endemic. Jpn J Cancer Research (Gann) 77: 21–3, 1986
Goto Y, Sugamura K, Hinuma Y: Healthy carriers of a human retrovirus, adult T-cell leukemia virus (ATLV): Demonstration by clonal culture of ATLV-carrying T cells from peripheral blood. Proc Nat Acad Sci 79: 4780–2, 1982
Tanaka Y, Koyanagi Y, Chosa T, Yamamoto N, Hinuma Y: Monoclonal antibody reactive with both p28 and p19 of adult T-cell leukemia virus-specific polypeptides. Gann 74: 327–30, 1983
Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y: Type-C virus particles in a cord T-cell line derived by cocultivation of normal human cord leukocytes and human leukemic T-cells. Nature 294: 770–1, 1981
Kinoshita K, Hino S, Amagasaki T, Yamada Y, Kamihira S, Ichimaru M, Munehisa T, Hinuma Y: Development of adult T-cell leukemia-lymphoma (ATL) in two anti-ATL-associated antigen-positive healthy adults. Gann 73: 684–5, 1982
Miyoshi I, Fujishita M, Taguchi H, Matsubayashi K, Miwa N, Tanioka Y: Natural infection in non-human primates with adult T-cell leukemia virus or a closely related agent. Int J Cancer 32: 333–6, 1983
Hayami M, Komuro A, Nozawa K, Ishikawa K, Yamamoto K, Ishida T, Honjo S, Hinuma Y: Prevalence of antibody to adult T-cell leukemia virus-associated antigen (ATLA) in Japanese monkeys and other non-human primates. Int J Cancer 33: 179–83, 1983
Yamamoto N, Hinuma Y, zur Hausen H, Schneider J, Hunsmann G: African green monkeys are infected with adult T-cell leukemia virus or a closely related agent. Lancet I: 240–1, 1983
Srivastava BIS, Wong-Staal F, Getchell JP: Human T-cell leukemia virus I provirus and antibodies in a captive gorilla with non-Hodgkin's lymphoma. Cancer Research 46 (9): 4756–8, 1986
Tsujimoto H, Noda Y, Ishikawa K, Nakamura H, Fukasawa M, Sakakibara I, Sasagawa A, Honjo S, Hayami M: Development of adult T-cell leukemia-like disease in African Green Monkey associated with clonal integration of simian T-cell leukemia virus type I. Cancer Res 47: 269–74, 1987
Kinoshita K, Hino S, Amagasaki T, Ikeda S, Yamada Y, Suzuyama J, Momita S, Toriya K, Kamihira S, Ichimaru M: Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Jpn J Cancer Research (Gann) 75: 103–5, 1984
Nakano S, Ando Y, Ichijo M, Moriyama L, Saito S, Sugimura K, Hinuma Y: Search for possible routes of vertical and horizontal transmission of adult T-cell leukemia virus. Jpn J Cancer Res (Gann) 75: 1044–5, 1984
Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, Tsuji Y, Miyamoto T: Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res 76: 474–80, 1985
Hino S, Doi H, Yoshikuni H, Sugiyama H, Ishimaru T, Yamabe T, Tsuji Y, Miyamoto T: HTLV-I carrier mothers with high-titer antibody are at high risk as a source of infection. Jpn J Cancer Res 78: 1156–8, 1987
Ando Y, Nakano S, Saito K, Shimamoto I, Ichijo M, Toyama T, Hinuma Y: Transmission of adult T-cell leukemia retrovirus (HTLV-I) from mother to child: comparison of bottle-with breast-fed babies. Jpn J Cancer Res 78: 322–4, 1987
Kinoshita K, Amagasaki T, Hino S, Doi H, Yamanouchi K, Ban N, Momita S, Ikeda S, Kamihira S, Ichimaru M, Katamine S, Miyamoto T, Tsuji Y, Ishimaru T, Yamabe T, Ito M, Kamura S, Tsuda T: Milk-borne transmission of HTLV-I from carrier mothers to their children. Jpn J Cancer Res 68: 674–80, 1987
Kusuhara K, Sonoda S, Takahashi K, Tokugawa K, Fukushige J, Ueda K: Mother-to-child transmission to human T-cell leukemia virus type I (HTLV-I): A fifteen-year follow-up study in Okinawa, Japan. Int J Cancer 40: 755–7, 1987
Miyoshi I, Yoshimoto S, Fujishita M, Taguchi H, Kubonishi I, Niiya K, Minezawa M: Natural adult T-cell leukemia virus infection in Japanese monkeys. Lancet II: 658, 1982
Tajima K, Kamura S, Ito S, Ito M, Nagatomo M, Kinoshita K, Ikeda S: Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: A report of the community-based co-operative study in Tsuchima, Japan. Int J Cancer 40: 741–6, 1987
Okochi K, Sato H, Hinuma Y: A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 46: 245–53, 1983
Sato H, Okochi K: Transmission of human T-cell leukemia virus (HTLV-I) by blood transfusion: Demonstration of proviral DNA in recipients' blood lymphocytes. Int J Cancer 37: 395–400, 1986
Tajima K, Tominaga S, Shimizu H, Suchi T: A hypothesis on the etiology of adult T-cell leukemia/lymphoma. Gann 72: 684–91, 1981
Tajima K, Fujita K, Tsukidate S, Oda T, Tominaga S, Suchi T, Hinuma Y: Seroepidemiological studies on the effects of filarial parasites on infestation of adult T-cell leukemia virus in the Goto Islands, Japan. Gann 74: 188–91, 1983
Nakada K, Kohakura M, Komoda H, Hinuma Y: High incidence of HTLV antibody in carriers of strongyloides stercoralis. Lancet I: 663, 1984
Tajima K, Tominaga S, Suchi T, Fujita K, Oda T, Tochikura T, Hinuma Y: Sero-epidemiological analysis of antibody expression against natural infection with ATLV among healthy inhabitants in the Goto Islands, Japan: An interim report. In: Haden RA (ed) Manipulation of Host Defense Mechanisms, Proceedings Book—The Fifth Symposium. Exerpta Medica Asia 115–23, 1984
Miyamoto T, Hino S, Muneshita T: Seroepidemiological studies of antibody antigens against expressed on adult T-cell leukemia cells in Nagasaki area. Leukemia Reviews International. 105–6, 1983
Hinuma Y, Chosa T, Komoda H, Mori I, Suzuki T, Tajima K, Pan I-H, Lee M: Sporadic retrovirus (ATLV)-seropositive individuals outside Japan. Lancet I: 824–5, 1983
Blattner WA, Clark JW, Gibbs WN, Williams CKO, Nomura A, Mann D, Sainger C, Robert-Guroff M, Gallo RC: Epidemiology and relationship to disease. In: Retrovirus in Human Lymphoma/leukemia. Proc 15th Int Symp Princess Takamatsu Cancer Fund, pp 23–4, 1984
Gallo RC, Sliski A, Wong-Staal F: Origin of human T-cell leukemia-lymphoma virus. Lancet II: 962–3, 1983
Ishida T, Yamamoto K, Omoto K, Iwanafa M, Osata T, Hinuma Y: Prevalence of a human retrovirus in native Japanese: evidence for a possible ancient origin. J Infection ii: 153–7, 1985
Hinuma Y: Seroepidemiology of adult T-cell leukemia virus (HTLV-I/ATLV): Origin of virus carriers in Japan. AIDS Res 2: s17–21, 1986
Tajima K, Kuroishi T: Estimation of incidence rate of ATL among ATLV-carriers in Kyushu, Japan. Jpn J Clin Oncol 15, 423–30, 1985
Kondo T, Kono H, Nonaka N, Miyamoto N, Bando F, Inoue H, Miyoshi I, Hinuma Y, Hanaoka M: Risk of adult T-cell leukemia/lymphoma in HTLV-I carriers. Lancet II: 159, 1987
The T- and B-cell Malignancy Study Group: The third nationwide study on adult T-cell leukemia/lymphoma (ATL) in Japan: characteristic patterns of HLA antigens and HTLV-I infection in ATL patients and their relatives. Int J Cancer 41: 505–12, 1988
Tajima K, Tominaga S, Suchi T, Fukui H, Komoda H, Hinuma Y: HTLV-I carriers among migrants from an ATL-endemic area to ATL non-endemic metropolitan areas in Japan. Int J Cancer 37: 383–7, 1986
Tajima K, Akaza T, Koike K, Hinuma Y, Suchi T, Tominaga S: HLA antigens and adult T-cell leukemia virus infection: A community based study in the Goto Islands, Japan. Jpn J Clin Oncol 14: 347–52, 1984
Tanaka K, Sato H, Okochi K: HLA antigens in patients with adult T-cell leukemia. Tissue Antigens: 23: 81–3, 1984
Imai J, Hinuma Y: Epstein-Barr virus-specific antibodies in patients with adult T-cell leukemia (ATL) and healthy ATL virus carriers. Int J Cancer 31: 197–200, 1983
Yamaguchi K, Matutes E, Catovsky D, Galton DAG, Nakada N, Takatsuki K: Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukemogenesis. Lancet II: 94–5, 1987
Asou N, Kumagai T, Uekihara S, Ishi M, Sato M, Sakai K, Nishimura H, Yamaguchi K, Takatsuki K. HTLV-I seroprevalence in patients with malignancy. Cancer 58: 903–7, 1986
Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I-associated myelopathy, A new clinical entity. Lancet I: 1031–2, 1986
Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calendar A, de The A: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet II: 407–9, 1985
Osame M, Matsumoto M, Usuku K, Izomo S, Ijichi N, Amitani H, Tara M, Igata A: Chronic progressive myelopathy associated with elevated antibodies to HTLV-I and adult T-cell leukemia-like cells. Ann Neurol 21: 117–22, 1987
Osame M, Igata A, Usuku K, Rosales R, Matsumoto M: Mother-to-child transmission in HTLV-I associated myelopathy. Lancet I: 106, 1987
Osame M, Izumo S, Igata A, Matsumoto M, Matsumoto T, Sonoda S, Tara M, Sibata Y: Blood transfusion and HTLV-I associated myelopathy. Lancet II: 104–5, 1986
Usuku K, Sonoda S, Osame M, Yashiki S, Takahashi K, Matsumoto M, Sawada T, Tsuji K, Tara M, Igata A: HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma. Ann Neurol 23: s143–50, 1988
Ohtsu T, Tsugane S, Tobinai K, Shimoyama M, Nanri S, Watanabe S: Prevalence of antibodies to human T-cell leukemia/lymphoma virus type I and human immunodeficiency virus in Japanese immigrant colonies in Bolivia and Bolivian natives. Jpn J Cancer Res 78: 1347–53, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tajima, K. Malignant lymphomas in Japan: Epidemiological analysis of adult T-cell leukemia/lymphoma (ATL). Cancer Metast Rev 7, 223–241 (1988). https://doi.org/10.1007/BF00047753
Issue Date:
DOI: https://doi.org/10.1007/BF00047753